Denlay Pharma Private Limited - Company Profile

It is a professional services private limited company based in Bareilly, Uttar Pradesh, India, established in 2015.
2015 Bareilly, Uttar Pradesh, India Active
Last Updated:
Access Report
About Denlay Pharma Private Limited

Denlay Pharma Private Limited, a active private limited company, was established on 27 March 2015 in Bareilly, Uttar Pradesh, India. Engaging in tax consultant within the professional services sector, it holds CIN: U74120UP2015PTC069818. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.10 M.

Formerly known as Zolamic Pharma Private Limited. It upholds a compliant status. Its leadership includes Navin Chandra Pathak (Director), Nazar Hasan Khan (Director). Its latest AGM occurred on 23 August 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Harish Chandra Pathak 811, Balaji Mandir Colony, Rajendra Naga, R, Bareilly, Uttar Pradesh, 243122.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120UP2015PTC069818

  • Registration Number

    069818

  • Incorporation Date

    27 March 2015

  • Authorized Capital

    ₹0.40 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.40 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Denlay Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Denlay Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Denlay Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Navin Chandra Pathak Director 27 Mar 2015 Current
Nazar Hasan Khan Director 27 Mar 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Denlay Pharma.

Denlay Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Denlay Pharma revenue growth over time
Denlay Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Denlay Pharma?

In 2017, Denlay Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Denlay Pharma?

Unlock and access historical data on people associated with Denlay Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Denlay Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Denlay Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Denlay Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Denlay Pharma Private Limited last Annual general meeting of members was held on 23 Aug 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Denlay Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    The activity Navin Chandra Pathak was appointed as a Director was appointed as a Director on 27 Mar 2015 & has been associated with this company since 10 years 10 months . was completed.

  • Director Appointment

    Nazar Hasan Khan was appointed as a Director was appointed as a Director on 27 Mar 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Denlay Pharma Private Limited was registered on 27 Mar 2015 with Roc Kanpur & aged 10 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Denlay Pharma Private Limited?

The CIN of Denlay Pharma Private Limited is U74120UP2015PTC069818.

Where is Denlay Pharma Private Limited headquartered?

Denlay Pharma Private Limited is headquartered at C/O Harish Chandra Pathak 811, Balaji Mandir Colony, Rajendra Naga, R, Bareilly, Uttar Pradesh, 243122.

When was Denlay Pharma Private Limited incorporated?

Denlay Pharma Private Limited was incorporated on 27 March 2015.

Who are the current directors of Denlay Pharma Private Limited?

The current directors of Denlay Pharma Private Limited are

What is the primary industry of Denlay Pharma Private Limited?

The primary industry of Denlay Pharma Private Limited is Professional Services.

Is Denlay Pharma Private Limited a listed company?

Denlay Pharma Private Limited is unlisted.

What is the capital structure of Denlay Pharma Private Limited?

The authorized capital of Denlay Pharma Private Limited is ₹0.40 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Denlay Pharma Private Limited?

The compliance status of Denlay Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available